Depression is a common comorbidity in those with multiple sclerosis (MS) and is associated with faster MS disability progression. Identifying who may be at higher risk for depression or faster disease activity or progression may facilitate earlier identification. We will examine the polygenicity of comorbid depression in MS and whether it is associated with MS disease activity & disability progression in multiple cohorts from Canada, the USA, Sweden, and UK Biobank.